| Literature DB >> 31365467 |
Aisylu S Gaifullina1,2, Joanna Lazniewska1, Elena V Gerasimova2, Gulshat F Burkhanova2, Yuriy Rzhepetskyy1, Andriy Tomin1, Paula Rivas-Ramirez1, Junting Huang3, Leos Cmarko1, Gerald W Zamponi3, Guzel F Sitdikova2, Norbert Weiss1.
Abstract
Homocysteinemia is a metabolic condition characterized by abnormally high level of homocysteine in the blood and is considered to be a risk factor for peripheral neuropathy. However, the cellular mechanisms underlying toxic effects of homocysteine on the processing of peripheral nociception have not yet been investigated comprehensively. Here, using a rodent model of experimental homocysteinemia, we report the causal association between homocysteine and the development of mechanical allodynia. Homocysteinemia-induced mechanical allodynia was reversed on pharmacological inhibition of T-type calcium channels. In addition, our in vitro studies indicate that homocysteine enhances recombinant T-type calcium currents by promoting the recycling of Cav3.2 channels back to the plasma membrane through a protein kinase C-dependent signaling pathway that requires the direct phosphorylation of Cav3.2 at specific loci. Altogether, these results reveal an unrecognized signaling pathway that modulates the expression of T-type calcium channels, and may potentially contribute to the development of peripheral neuropathy associated with homocysteinemia.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31365467 DOI: 10.1097/j.pain.0000000000001669
Source DB: PubMed Journal: Pain ISSN: 0304-3959 Impact factor: 6.961